Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
16,19 USD | +0,81% | +3,19% | -9,81% |
Attività
Numero di dipendenti: 344
Vendite per attività
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Gene Therapy
100,0
%
| 113 | 100,0 % | 90 | 100,0 % | -19,94% |
Vendite per regione
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
International
68,0
%
| 62 | 55,0 % | 61 | 68,0 % | -1,02% |
United States
32,0
%
| 39 | 35,0 % | 29 | 32,0 % | -26,81% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Kenneth Mills
FOU | Founder | 49 | 16/07/08 |
Vit Vasista
DFI | Director of Finance/CFO | 56 | 01/08/09 |
Chief Tech/Sci/R&D Officer | - | 01/11/15 | |
Olivier Danos
CTO | Chief Tech/Sci/R&D Officer | 66 | 28/03/17 |
Stephen Pakola
CTO | Chief Tech/Sci/R&D Officer | 55 | 17/04/19 |
Curran Simpson
COO | Chief Operating Officer | 62 | 01/08/15 |
Shiva G. Fritsch
IRO | Public Communications Contact | - | 01/01/17 |
Laura Coruzzi
PRN | Corporate Officer/Principal | 71 | - |
Ram Palanki
PRN | Corporate Officer/Principal | 48 | 01/08/18 |
General Counsel | 53 | 01/08/16 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
George Migausky
BRD | Director/Board Member | 69 | 03/09/21 |
David Stump
BRD | Director/Board Member | 74 | 15/10/15 |
Director/Board Member | 71 | 01/05/15 | |
Daniel Tassé
BRD | Director/Board Member | 64 | 15/08/16 |
Director/Board Member | 65 | 25/05/18 | |
Allan Fox
CHM | Chairman | 76 | 01/01/09 |
Kenneth Mills
FOU | Founder | 49 | 16/07/08 |
Jennifer Zachary
BRD | Director/Board Member | 46 | 03/06/22 |
Jean Bennett
BRD | Director/Board Member | 69 | 01/03/21 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 49 042 717 | 45 180 406 ( 92,12 %) | 0 | 92,12 % |
Coordinate società
Settore
Vendite per regione
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
-9,81% | 794 Mln | |
-2,31% | 103 Mrd | |
+0,56% | 95,28 Mrd | |
+1,69% | 22,15 Mrd | |
-17,37% | 21,02 Mrd | |
-9,30% | 18,15 Mrd | |
-41,01% | 16,73 Mrd | |
-14,85% | 16,05 Mrd | |
+3,21% | 13,68 Mrd | |
+33,54% | 12,17 Mrd |
- Borsa valori
- Azioni
- Azione RGNX
- Società REGENXBIO Inc.